plasmacytoma
Showing 1 - 9 of 9
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Plasmacytoma, POEMS Syndrome Trial in Rochester (Dexamethasone, Ixazomib Citrate, Lenalidomide)
Active, not recruiting
- Plasmacytoma
- POEMS Syndrome
- Dexamethasone
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
May 26, 2022
Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,
Active, not recruiting
- Plasma Cell Leukemia
- +2 more
- Dexamethasone
- +3 more
-
Rochester, Minnesota
- +1 more
May 19, 2022
Plasmacytoma Trial in São Paulo (SBRT)
Terminated
- Plasmacytoma
- SBRT
-
São Paulo, Sao Paulo, BrazilSao Paulo Cancer Institute
Mar 28, 2022
Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA Trial in United States (milatuzumab)
Completed
- Multiple Myeloma
- +2 more
- milatuzumab
-
Atlanta, Georgia
- +5 more
Aug 12, 2021
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Stanford (drug, radiation,
Completed
- Adenocarcinoma of the Prostate
- +5 more
- sodium selenite
- +4 more
-
Stanford, CaliforniaStanford University, School of Medicine
Feb 14, 2020
Multiple Myeloma in Relapse, Plasmacytoma, Daratumumab Trial in Seoul (Drug Combinations)
Unknown status
- Multiple Myeloma in Relapse
- +2 more
- Drug Combinations
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 21, 2019
Multiple Myeloma, Plasmacytoma Trial in United States (magnetic resonance imaging, positron emission tomography)
Terminated
- Multiple Myeloma
- Plasmacytoma
- magnetic resonance imaging
- positron emission tomography
-
Mobile, Alabama
- +25 more
Apr 21, 2017